Lee's Pharmaceutical Holdings Limited (FRA:L1PA)

Germany flag Germany · Delayed Price · Currency is EUR
0.1600
+0.0060 (3.90%)
Last updated: Jan 28, 2026, 9:55 AM CET
11.11%
Market Cap102.17M +6.1%
Revenue (ttm)155.81M +19.8%
Net Income10.61M +55.1%
EPS0.02 +55.1%
Shares Outn/a
PE Ratio9.63
Forward PEn/a
Dividend0.01 (3.26%)
Ex-Dividend DateSep 12, 2025
Volumen/a
Average Volume1,207
Open0.1600
Previous Close0.1540
Day's Range0.1600 - 0.1600
52-Week Range0.1310 - 0.2700
Betan/a
RSI44.75
Earnings DateMar 27, 2026

About FRA:L1PA

Lee's Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People's Republic of China, Hong Kong, and internationally. It focuses on various disease areas, such as cardiovascular, woman’s health, pediatrics, rare diseases, oncology, dermatology, and obstetrics. It operates in Proprietary and Generic Products; and Licensed-In Products segments. The Proprietary and Generic Products segment manufactures and sells Nadroparin Calcium injection and Livaracine to trea... [Read more]

Industry Pharmaceutical Preparations
Founded 1994
Employees 1,036
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol L1PA
Full Company Profile

Financial Performance

In 2024, FRA:L1PA's revenue was 1.40 billion, an increase of 32.95% compared to the previous year's 1.05 billion. Earnings were 93.10 million, an increase of 457.55%.

Financial numbers in HKD Financial Statements